Bioceres Crop Solutions (BIOX) has released an update.
Bioceres Crop Solutions has reported an 18% increase in fourth-quarter revenues, leading to a full-year total of $465 million, with a significant contribution from HB4 wheat sales. The company’s fiscal year 2024 ended with a GAAP net income of $6.2 million and a sturdy adjusted EBITDA of $81.4 million, maintaining stability despite a challenging year in agriculture. Additionally, the approval of HB4 wheat cultivation in the United States marks a milestone for Bioceres, poised to expand its market presence.
For further insights into BIOX stock, check out TipRanks’ Stock Analysis page.
